Department of Rehabilitation, Dapeng New District Nan'ao People's Hospital, Shenzhen, Guangdong Province, 518121, China.
Department of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, Guangdong Province, 518037, China.
Chin J Integr Med. 2022 Jun;28(6):483-491. doi: 10.1007/s11655-021-3525-0. Epub 2021 Dec 15.
To evaluate the effects of interactive dynamic scalp acupuncture (IDSA), simple combination therapy (SCT), and traditional scalp acupuncture (TSA) on motor function and gait of the lower limbs in post-stroke hemiplegia patients.
A total of 231 patients with post-stroke hemiplegia was randomly divided into IDSA (78 cases), SCT (78 cases), and TSA (75 cases) groups by a random number table. Scalp acupuncture (SA) and lower-limb robot training (LLRT) were both performed in the IDSA and SCT groups. The patients in the TSA group underwent SA and did not receive LLRT. The treatment was administered once daily and 6 times weekly for 8 continuous weeks, each session lasted for 30 min. The primary outcome measures included Fugl-Meyer assessment of the lower extremity (FMA-LE), berg balance scale (BBS), modified barthel index (MBI), and 6-min walking test (6MWT). The secondary outcome measures included stride frequency (SF), stride length (SL), stride width (SW), affected side foot angle (ASFA), passive range of motion (PROM) of the affected hip (PROM-H), knee (PROM-K) and ankle (PROM-A) joints. The patients were evaluated before treatment, at 1- and 2-month treatment, and 1-, and 2-month follow-up visits, respectively. Adverse events during 2-month treatment were observed.
Nineteen patients withdrew from the trial, with 8 in the IDSA and 5 in the SCT groups, 6 in the TSA group. The FMA-LE, BBS, 6MWT and MBI scores in the IDSA group were significantly increased after 8-week treatment and 2 follow-up visits compared with the SCT and TSA groups (P<0.05 or P<0.01). Compared with pre-treatment, the grade distribution of BBS and MBI scores in the 3 groups were significantly improved at 1, 2-month treatment and 2 follow-up visits (P<0.05 or P<0.01). The SF, PROM-H, PROM-K and PROM-A in the IDSA group was significantly increased compared with the SCT and TSA groups after 8-week of treatment (P<0.05 or P<0.01). Compared with the SCT group, ASFA of the IDSA group was significantly reduced after 8-week of treatment (P<0.05). SF, SL, PROM-K and PROM-A were significantly increased at the 2nd follow-up visit whereas the ASFA was significantly reduced in the IDSA group compared with the SCT groups at 1st follow-up visit (P<0.05 or P<0.01). The SF was significantly increased in the SCT group compared with the TSA group after 8-week treatment (P<0.05). Compared with the TSA group, PROM-K, PROM-A were significantly increased at the 2nd follow-up visit (P<0.05).
The effects of IDSA on lower-limb motor function and walking ability of post-stroke patients were superior to SCT and TSA. The SCT was comparable to TSA treatment, and appeared to be superior in improving the motion range of the lower extremities. (Registration No. ChiCTR1900027206).
评价互动式动态头皮针刺(IDSA)、单纯组合疗法(SCT)和传统头皮针刺(TSA)对脑卒中后偏瘫患者下肢运动功能和步态的影响。
将 231 例脑卒中后偏瘫患者采用随机数字表法分为 IDSA 组(78 例)、SCT 组(78 例)和 TSA 组(75 例)。IDSA 和 SCT 组均进行头皮针刺(SA)和下肢机器人训练(LLRT)。TSA 组仅进行 SA 治疗,不接受 LLRT。治疗每日 1 次,每周 6 次,连续 8 周,每次 30 min。主要结局指标包括下肢 Fugl-Meyer 评估(FMA-LE)、伯格平衡量表(BBS)、改良巴氏指数(MBI)和 6 分钟步行测试(6MWT)。次要结局指标包括步频(SF)、步长(SL)、步宽(SW)、患侧足角(ASFA)、患髋(PROM-H)、膝(PROM-K)和踝(PROM-A)关节的被动活动度(PROM)。分别于治疗前、治疗 1 个月和 2 个月及治疗后 1 个月和 2 个月进行评估。观察治疗 2 个月期间的不良反应。
19 例患者退出试验,IDSA 组 8 例,SCT 组 5 例,TSA 组 6 例。与 SCT 和 TSA 组相比,IDSA 组治疗 8 周及治疗后 2 次随访时的 FMA-LE、BBS、6MWT 和 MBI 评分显著升高(P<0.05 或 P<0.01)。与治疗前相比,3 组 BBS 和 MBI 评分的等级分布在治疗 1、2 个月及治疗后 2 次随访时均明显改善(P<0.05 或 P<0.01)。与 SCT 和 TSA 组相比,IDSA 组治疗 8 周后 SF、PROM-H、PROM-K 和 PROM-A 显著增加(P<0.05 或 P<0.01)。与 SCT 组相比,IDSA 组治疗 8 周后 ASFA 显著降低(P<0.05)。与 SCT 组相比,IDSA 组在治疗后第 2 次随访时 SF、SL、PROM-K 和 PROM-A 显著增加,而在第 1 次随访时 ASFA 显著降低(P<0.05 或 P<0.01)。与 TSA 组相比,SCT 组治疗 8 周后 SF 显著增加(P<0.05)。与 TSA 组相比,治疗后第 2 次随访时 PROM-K 和 PROM-A 显著增加(P<0.05)。
与 SCT 和 TSA 相比,IDSA 对脑卒中后患者下肢运动功能和步行能力的改善效果优于 SCT 和 TSA。SCT 与 TSA 治疗效果相当,但在改善下肢运动范围方面似乎更具优势。(注册号:ChiCTR1900027206)